Tg Therapeutics, Inc.
Get Full AccessDescription
- TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Currently, the company is developing two therapies targeting hematological malignancies. TG-1101 (ublituximab) is a novel, glycoengineered monoclonal antibody that targets a specific and unique epitope on the CD20 antigen found on mature B-lymphocytes. TG Therapeutics is also developing TGR-1202, an orally available PI3K delta inhibitor. The delta isoform of PI3K is strongly expressed in cells of hematopoietic origin and is believed to be important in the proliferation and survival of B-lymphocytes. Both TG-1101 and TGR-1202 are in clinical development for patients with hematologic malignancies. The Company also has pre-clinical programs to develop IRAK4 inhibitors, and anti-PD-L1 and anti-GITR antibodies. TG Therapeutics is headquartered in New York City and is traded on NASDAQ under the ticker symbol TGTX.
-
Headquarters:2 Gansevoort Street , New York, New York, United States
More -
Phone Number: +1 212-554-4484
-
Website: https://www.tgtherapeutics.com
-
Employees:189
-
Revenue:$100 - 250M
-
Legal Name:Tg Therapeutics, Inc.
-
Tg Therapeutics, Inc.'s Social Media
-
Is this data correct?
-
| NAICS Code: 511210 |
Show More
Frequently Asked Questions regarding Tg Therapeutics, Inc.
-
Where are Tg Therapeutics, Inc.'s Headquarters?
Tg Therapeutics, Inc.'s Headquarters are in 2 Gansevoort Street ,New York,New York,United States
-
What is Tg Therapeutics, Inc.'s phone number?
Tg Therapeutics, Inc.'s phone number is +1 212-554-4484
-
What is Tg Therapeutics, Inc.'s official website?
Tg Therapeutics, Inc.'s official website is https://www.tgtherapeutics.com
-
What is Tg Therapeutics, Inc.'s Revenue?
Tg Therapeutics, Inc.'s revenue is $100 - 250M
-
What is Tg Therapeutics, Inc.'s NAICS code?
Tg Therapeutics, Inc.'s NAICS code is 511210
-
How many employees are working in Tg Therapeutics, Inc.
Tg Therapeutics, Inc. has 189 employees
-
What is Tg Therapeutics, Inc.'s Industry?
Tg Therapeutics, Inc. is in the industry of Biotechnology
-
Who is Tg Therapeutics, Inc.'s Chief Operating Officer?
Tg Therapeutics, Inc.'s Chief Operating Officer is Peter Sportelli

